Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Marta Vidaurreta Josep Tabernero Caturla Eduardo Díaz-Rubio |
| Publication date | May 29, 2012 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |